Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/136450Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Fernando Fernandez-Llimos | |
| dc.creator | Deise Regina Sprada Pontarolli | |
| dc.creator | Margely de Souza Nunes | |
| dc.creator | Paula Rossignoli | |
| dc.creator | Priscila Marys Limberger | |
| dc.date.accessioned | 2022-09-08T23:58:45Z | - |
| dc.date.available | 2022-09-08T23:58:45Z | - |
| dc.date.issued | 2020 | |
| dc.identifier.isbn | 978-65-00-00672-8 | |
| dc.identifier.other | sigarra:499660 | |
| dc.identifier.uri | https://hdl.handle.net/10216/136450 | - |
| dc.language.iso | por | |
| dc.rights | restrictedAccess | |
| dc.title | Resultados da estratégia da SES/PR perante a incorporação de biossimilar de Etanercepte 50 mg no Componente Especializado da Assistência Farmacêutica | |
| dc.type | Livro | |
| dc.contributor.uporto | Faculdade de Farmácia | |
| Appears in Collections: | FFUP - Livro | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 499660.pdf Restricted Access | 325.39 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.